Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NV5 Global | NVEE | Nov 27, 2024 | 21.59 | -2.62 |
NVE | NVEC | Nov 27, 2024 | 77.09 | +0.33 |
nVent Electric | NVT | Nov 27, 2024 | 76.54 | -1.88 |
NVIDIA | NVDA | Nov 27, 2024 | 135.34 | -1.15 |
Nvni Group | NVNI | Nov 27, 2024 | 0.77 | +2.04 |
NVR | NVR | Nov 27, 2024 | 9 193.62 | -0.31 |
NWTN B | NWTN | Nov 27, 2024 | 1.24 | +6.90 |
NXG NextGen Infrastructure Income Fund | NXG | Nov 27, 2024 | 51.40 | +1.10 |
NXP Semiconductors | NXPI | Nov 27, 2024 | 226.53 | -0.93 |
Nxu | NXU | Nov 27, 2024 | 0.27 | +2.47 |
NYLI CBRE Global Infrastructure Megatrends Term Fund | MEGI | Nov 27, 2024 | 13.59 | +1.19 |
NYSE Arca Biotech Index First Trust | FBT | Nov 27, 2024 | 174.48 | +1.05 |
Nyse Composite | NYA | Nov 27, 2024 | 20 210.00 | +0.03 |
Nyxoah SA | NYXH | Nov 27, 2024 | 8.39 | +3.07 |
O-I Glass | OI | Nov 27, 2024 | 12.69 | +0.71 |
Oak Valley Bancorp | OVLY | Nov 27, 2024 | 31.26 | +0.94 |
Oak Woods Acquisition | OAKU | Nov 27, 2024 | 11.26 | +0.09 |
Oaktree Acquisition III Life Sciences Unit | OACCU | Nov 27, 2024 | 10.06 | 0.00 |
Oaktree Capital A Pref | OAK-A | Nov 27, 2024 | 23.59 | +0.26 |
Oaktree Capital Group B Pref | OAK-B | Nov 27, 2024 | 22.91 | +0.09 |
Oaktree Specialty | OCSL | Nov 27, 2024 | 16.28 | +1.75 |
Oatly ADR | OTLY | Nov 27, 2024 | 0.72 | -0.24 |
Oblong | OBLG | Nov 27, 2024 | 3.51 | -0.57 |
Occidental Petroleum | OXY | Nov 27, 2024 | 50.32 | +0.94 |
Ocean Biomedical | OCEA | Nov 27, 2024 | 0.71 | -1.84 |
Ocean Power Technologies | OPTT | Nov 27, 2024 | 0.37 | +26.28 |
Oceaneering International | OII | Nov 27, 2024 | 29.79 | +1.71 |
OceanFirst Financial | OCFC | Nov 27, 2024 | 20.84 | -1.47 |
OceanFirst Pref | OCFCP | Nov 27, 2024 | 25.20 | 0.00 |
OceanPal | OP | Nov 27, 2024 | 1.41 | -0.70 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.